147 related articles for article (PubMed ID: 24623337)
1. [Endometrioid borderline tumor of the testis. A rare cause of cystic neoplasia].
Obliers A; Hinz R; Erbersdobler A
Pathologe; 2014 Sep; 35(5):504-7. PubMed ID: 24623337
[TBL] [Abstract][Full Text] [Related]
2. A case of intratesticular endometrioid papillary cystadenocarcinoma.
Numakura K; Tsuchiya N; Tsuruta H; Obara T; Saito M; Inoue T; Narita S; Horikawa Y; Satoh S; Nanjyo H; Habuchi T
Jpn J Clin Oncol; 2011 May; 41(5):674-6. PubMed ID: 21474549
[TBL] [Abstract][Full Text] [Related]
3. Ovarian type surface epithelial carcinoma of the testis with delayed metastatic spread.
Maruschke M; Schmidt W; Casper J; Hakenberg OW
Urol Int; 2008; 81(1):119-21. PubMed ID: 18645284
[TBL] [Abstract][Full Text] [Related]
4. Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor: report of a series of cases.
Mansor S; McCluggage WG
Int J Gynecol Pathol; 2014 Sep; 33(5):470-6. PubMed ID: 25083962
[TBL] [Abstract][Full Text] [Related]
5. Paratesticular endometrioid adenocarcinoma of the ovarian surface epithelial type with neuroendocrine differentiation: an undescribed entity.
Mundada A; Kakkar A; Menon S
Histopathology; 2022 Jan; 80(2):443-445. PubMed ID: 34245593
[No Abstract] [Full Text] [Related]
6. Borderline serous papillary tumor of the testis.
Fonseca D; Manasa PL; Sharma R; Giridhar A
Indian J Pathol Microbiol; 2020; 63(4):618-619. PubMed ID: 33154318
[TBL] [Abstract][Full Text] [Related]
7. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
[TBL] [Abstract][Full Text] [Related]
8. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
9. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A.
Wu CH; Mao TL; Vang R; Ayhan A; Wang TL; Kurman RJ; Shih IeM
Int J Gynecol Pathol; 2012 Jul; 31(4):297-303. PubMed ID: 22653341
[TBL] [Abstract][Full Text] [Related]
10. KRAS-mutated Uterine Endometrioid Carcinoma With Extensive Surface Changes Resulting in Striking Morphologic Mimicry of an Ovarian Serous Borderline Tumor.
Kir G; Olgun ZC; Gunel H; Ozen F; McCluggage WG
Int J Gynecol Pathol; 2020 Nov; 39(6):573-577. PubMed ID: 31855953
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
[TBL] [Abstract][Full Text] [Related]
12. Seromucinous borderline tumor of the testis-A case report.
Scholz B; Beckert M; Mordstein V; Hohmann N; Walther R; Papadopoulos T
Hum Pathol; 2017 Feb; 60():188-191. PubMed ID: 27597522
[TBL] [Abstract][Full Text] [Related]
13. "Surface epithelial changes" in uterine endometrioid carcinoma mimicking micropapillary serous borderline tumor of ovary: report of two cases and review of the literature.
Singh K; Simon RA; Zhang C; Quddus MR
Diagn Pathol; 2011 Jan; 6():13. PubMed ID: 21272308
[TBL] [Abstract][Full Text] [Related]
14. Serous papillary cystic tumor of borderline malignancy with focal carcinoma arising in testis: case report with immunohistochemical and ultrastructural observations.
Remmele W; Kaiserling E; Zerban U; Hildebrand U; Bennek M; Jacobi-Nolde P; Pinkenburg FA
Hum Pathol; 1992 Jan; 23(1):75-9. PubMed ID: 1544675
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors.
Yasunaga M; Ohishi Y; Oda Y; Misumi M; Iwasa A; Kurihara S; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675
[TBL] [Abstract][Full Text] [Related]
16. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.
McCluggage WG
Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157
[TBL] [Abstract][Full Text] [Related]
17. Pathology of Endometrioid and Clear Cell Carcinoma of the Ovary.
Fadare O; Parkash V
Surg Pathol Clin; 2019 Jun; 12(2):529-564. PubMed ID: 31097114
[TBL] [Abstract][Full Text] [Related]
18. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
[TBL] [Abstract][Full Text] [Related]
19. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary.
Bell KA; Kurman RJ
Am J Surg Pathol; 2000 Nov; 24(11):1465-79. PubMed ID: 11075848
[TBL] [Abstract][Full Text] [Related]
20. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
Murali R; Davidson B; Fadare O; Carlson JA; Crum CP; Gilks CB; Irving JA; Malpica A; Matias-Guiu X; McCluggage WG; Mittal K; Oliva E; Parkash V; Rutgers JKL; Staats PN; Stewart CJR; Tornos C; Soslow RA
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S40-S63. PubMed ID: 30550483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
